First-Line erlotinib therapy until and beyond response evaluation criteria in solid tumors progression in asian patients with epidermal growth factor receptor mutation-positive non-small-cell lung cancer: the ASPIRATION Study - Park, K; Yu, C J; Kim, S W (JAMA Oncol, 2016)
et al.